ESSA Pharma Inc. ("ESSA" or the "Company") announced that Ari Brettman, M.D., has stepped down from ESSA's Board of Directors, which he has been a member of since 2019. Dr. Brettman is a Managing Director of Blackstone'sLife Science Group and will be assuming more responsibilities in this role.